No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs13415952 |
chr2:37947754-37947755 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
2 |
rs546684465 |
chr2:37947757-37947758 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs76399588 |
chr2:37947788-37947789 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs140957126 |
chr2:37947831-37947832 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs572283121 |
chr2:37947846-37947847 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs188111705 |
chr2:37947856-37947857 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs57707814 |
chr2:37947890-37947891 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs150192083 |
chr2:37947892-37947893 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs112661563 |
chr2:37947911-37947912 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs73928910 |
chr2:37947922-37947923 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs561621978 |
chr2:37947926-37947927 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs181988849 |
chr2:37947929-37947930 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs541713040 |
chr2:37947932-37947933 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs148996475 |
chr2:37947968-37947969 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs4552170 |
chr2:37947986-37947987 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs576825845 |
chr2:37947992-37947993 |
Weak transcription Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs533501245 |
chr2:37948007-37948008 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs569537251 |
chr2:37948057-37948058 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs187049112 |
chr2:37948073-37948074 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs17021250 |
chr2:37948138-37948139 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs145812508 |
chr2:37948148-37948149 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs553098401 |
chr2:37948196-37948197 |
Enhancers Weak transcription Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs138393624 |
chr2:37948213-37948214 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs567285717 |
chr2:37948222-37948223 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs533309459 |
chr2:37948253-37948254 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs534681527 |
chr2:37948276-37948277 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs552979958 |
chr2:37948284-37948285 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs142934481 |
chr2:37948298-37948299 |
Enhancers Flanking Active TSS Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs75173369 |
chr2:37948415-37948416 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs557896861 |
chr2:37948444-37948445 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs576161104 |
chr2:37948452-37948453 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs557476196 |
chr2:37948474-37948475 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs149031583 |
chr2:37948476-37948477 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs73928911 |
chr2:37948480-37948481 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs397813281 |
chr2:37948481-37948482 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs192229132 |
chr2:37948493-37948494 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs555518675 |
chr2:37948512-37948513 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs183558528 |
chr2:37948521-37948522 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs148217991 |
chr2:37948560-37948561 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs12467084 |
chr2:37948570-37948571 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
41 |
rs541022778 |
chr2:37948574-37948575 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs534016034 |
chr2:37948578-37948579 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs555237867 |
chr2:37948598-37948599 |
Enhancers Flanking Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs186926349 |
chr2:37948611-37948612 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs578164489 |
chr2:37948613-37948614 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs567366594 |
chr2:37948625-37948626 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs537497680 |
chr2:37948631-37948632 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs545377560 |
chr2:37948638-37948639 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs367774500 |
chr2:37948712-37948713 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs531024917 |
chr2:37948721-37948722 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|